{"id":"https://openalex.org/W2586628510","doi":"https://doi.org/10.1182/blood.v128.22.4412.4412","title":"The Impact of Maintenance Lenalidomide on the Mutational Status of the Myeloma Clone at Relapse in the NCRI Myeloma XI Trial for Newly Diagnosed Multiple Myeloma Patients (NDMM)","display_name":"The Impact of Maintenance Lenalidomide on the Mutational Status of the Myeloma Clone at Relapse in the NCRI Myeloma XI Trial for Newly Diagnosed Multiple Myeloma Patients (NDMM)","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2586628510","doi":"https://doi.org/10.1182/blood.v128.22.4412.4412","mag":"2586628510"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.4412.4412","doi":"https://doi.org/10.1182/blood.v128.22.4412.4412","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.4412.4412","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058317897","display_name":"John R Jones","orcid":"https://orcid.org/0000-0002-1401-6105","observed_orcids":["https://orcid.org/0000-0002-1401-6105"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John R Jones","raw_affiliation_strings":["Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052636654","display_name":"Niels Weinhold","orcid":"https://orcid.org/0000-0002-5464-3234","observed_orcids":["https://orcid.org/0000-0002-5464-3234"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niels Weinhold","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077766447","display_name":"Shweta S. Chavan","orcid":"https://orcid.org/0000-0001-9433-6936","observed_orcids":["https://orcid.org/0000-0001-9433-6936"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shweta S. Chavan","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072977279","display_name":"Charlotte Pawlyn","orcid":"https://orcid.org/0000-0002-7190-0028","observed_orcids":["https://orcid.org/0000-0002-7190-0028"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Pawlyn","raw_affiliation_strings":["Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035296945","display_name":"Lorenzo Melchor","orcid":"https://orcid.org/0000-0002-5322-2817","observed_orcids":["https://orcid.org/0000-0002-5322-2817"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lorenzo Melchor","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042419236","display_name":"David Allan Cairns","orcid":"https://orcid.org/0000-0002-2338-0179","observed_orcids":["https://orcid.org/0000-0002-2338-0179"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David A Cairns","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110454718","display_name":"Dil B Begum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dil B Begum","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111977149","display_name":"Charlotte A. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Smith","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058058171","display_name":"Sidra Ellis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sidra Ellis","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103080653","display_name":"Amy Price","orcid":"https://orcid.org/0000-0002-2789-2139","observed_orcids":["https://orcid.org/0000-0002-2789-2139"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amy Price","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085552743","display_name":"Amy L. Sherborne","orcid":"https://orcid.org/0000-0002-9717-4773","observed_orcids":["https://orcid.org/0000-0002-9717-4773"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Amy L Sherborne","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042516164","display_name":"Brian A. Walker","orcid":"https://orcid.org/0000-0002-8615-6254","observed_orcids":["https://orcid.org/0000-0002-8615-6254"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian A Walker","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084133067","display_name":"Christopher P. Wardell","orcid":"https://orcid.org/0000-0002-9416-7818","observed_orcids":["https://orcid.org/0000-0002-9416-7818"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher P Wardell","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038580329","display_name":"Gordon Cook","orcid":"https://orcid.org/0000-0003-1717-0412","observed_orcids":["https://orcid.org/0000-0003-1717-0412"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gordon Cook","raw_affiliation_strings":["University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083949340","display_name":"Matthew W. Jenner","orcid":"https://orcid.org/0000-0003-0216-7464","observed_orcids":["https://orcid.org/0000-0003-0216-7464"]},"institutions":[{"id":"https://openalex.org/I2802965805","display_name":"University Hospital Southampton NHS Foundation Trust","ror":"https://ror.org/0485axj58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802965805"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew W Jenner","raw_affiliation_strings":["University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom","institution_ids":["https://openalex.org/I2802965805"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035489508","display_name":"Nigel H. Russell","orcid":"https://orcid.org/0000-0003-1893-8155","observed_orcids":["https://orcid.org/0000-0003-1893-8155"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nigel H Russell","raw_affiliation_strings":["Nottingham University Hospital, Nottingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nottingham University Hospital, Nottingham, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053100242","display_name":"Mark Trehane Drayson","orcid":"https://orcid.org/0000-0002-1528-7564","observed_orcids":["https://orcid.org/0000-0002-1528-7564"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark T Drayson","raw_affiliation_strings":["Clinical Immunology, School of Immunity & Infection, University of Birmingham, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Immunology, School of Immunity & Infection, University of Birmingham, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063301766","display_name":"Roger G. Owen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roger G Owen","raw_affiliation_strings":["United Leeds Teaching Hospitals, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United Leeds Teaching Hospitals, Leeds, United Kingdom","institution_ids":["https://openalex.org/I2799390153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034560778","display_name":"Faith E. Davies","orcid":"https://orcid.org/0000-0002-3971-2393","observed_orcids":["https://orcid.org/0000-0002-3971-2393"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Faith E Davies","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073477610","display_name":"Martin Kaiser","orcid":"https://orcid.org/0000-0002-3677-4804","observed_orcids":["https://orcid.org/0000-0002-3677-4804"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin F Kaiser","raw_affiliation_strings":["Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081247376","display_name":"Graham Hunter Jackson","orcid":"https://orcid.org/0000-0003-0756-969X","observed_orcids":["https://orcid.org/0000-0003-0756-969X"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham H Jackson","raw_affiliation_strings":["Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017165070","display_name":"Walter Martin Gregory","orcid":"https://orcid.org/0000-0003-2641-8416","observed_orcids":["https://orcid.org/0000-0003-2641-8416"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Walter M Gregory","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111607029","display_name":"Melvyn F. Greaves","orcid":"https://orcid.org/0000-0002-7239-1384","observed_orcids":["https://orcid.org/0000-0002-7239-1384"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mel Greaves","raw_affiliation_strings":["The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100632493","display_name":"Gareth John Morgan","orcid":"https://orcid.org/0000-0002-4271-6360","observed_orcids":["https://orcid.org/0000-0002-4271-6360","https://orcid.org/0000-0002-1275-2010","https://orcid.org/0000-0001-7073-2723"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gareth J Morgan","raw_affiliation_strings":["Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR","institution_ids":["https://openalex.org/I79620101"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6336,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.77296027,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"128","issue":"22","first_page":"4412","last_page":"4412"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9520000219345093},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8429999947547913},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7110000252723694},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.7120000123977661},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8130000233650208},{"id":"https://openalex.org/keywords/mutational-load","display_name":"mutational load","score":0.6840000152587891},{"id":"https://openalex.org/keywords/cereblon","display_name":"cereblon","score":0.6420000195503235},{"id":"https://openalex.org/keywords/selective-pressure","display_name":"selection pressure","score":0.5680000185966492},{"id":"https://openalex.org/keywords/high-risk-disease","display_name":"high-risk disease","score":0.5600000023841858},{"id":"https://openalex.org/keywords/transplant-eligibility","display_name":"transplant eligibility","score":0.3319999873638153},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":0.6859999895095825},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9589999914169312},{"id":"https://openalex.org/keywords/secondary-malignancies","display_name":"secondary malignancies","score":0.36399999260902405},{"id":"https://openalex.org/keywords/clonal-architecture","display_name":"clonal architecture","score":0.6809999942779541},{"id":"https://openalex.org/keywords/whole-exome-sequencing","display_name":"exome sequencing","score":0.5429999828338623},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8389084339141846},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6673915982246399},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6399784684181213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6013261079788208},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5546483397483826},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.5402287244796753},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5067225098609924},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.44319018721580505},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12057632207870483}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.4412.4412","doi":"https://doi.org/10.1182/blood.v128.22.4412.4412","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.4412.4412","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2606703911","https://openalex.org/W2985382091","https://openalex.org/W2983001736","https://openalex.org/W3081877481","https://openalex.org/W2911291590","https://openalex.org/W2988064798","https://openalex.org/W2985727296","https://openalex.org/W7221131125","https://openalex.org/W3042018183","https://openalex.org/W2593617117"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"With":[2],"a":[3,35,91,110,171,189,290,298,303,434,492,556,561,580,695],"multifactorial":[4],"mechanism":[5],"of":[6,50,75,100,106,133,158,174,249,345,368,386,436,491,567,589,691,702,832,925],"action":[7,27],"and":[8,48,65,82,109,163,196,200,211,226,264,300,310,316,352,356,427,446,461,563,577,585,605,619,639,657,677],"excellent":[9],"PFS":[10],"associated":[11,504,524],"with":[12,30,39,233,497,505,525,596,630,636,665],"prolonged":[13],"exposure,":[14],"lenalidomide":[15],"(len)":[16],"is":[17,96,188,684,735],"an":[18,97,444,829],"attractive":[19],"candidate":[20],"for":[21,116,312,482,725,927],"maintenance":[22,101,161,204,231,276,364,676],"therapy.":[23],"Len":[24,162],"exerts":[25],"its":[26],"by":[28,137,243],"interaction":[29],"cereblon":[31],"(CRBN)":[32],"which":[33],"forms":[34],"ubiquitin":[36],"ligase":[37],"complex":[38],"cullin-4A":[40],"(CUL4),":[41],"damaged":[42],"DNA":[43,92],"binding":[44],"protein":[45],"1":[46,52,71],"(DDB1)":[47],"regulator":[49],"cullins":[51],"(ROC1).":[53],"Downstream":[54],"effects":[55],"are":[56],"mediated":[57],"via":[58],"Ikaros,":[59,541],"Aiolos,":[60,542],"MYC,":[61],"IRF4,":[62],"basigin":[63],"(BSG)":[64],"solute":[66],"carrier":[67],"family":[68],"16":[69],"member":[70],"(SLC16A1).":[72],"The":[73,270,305,342,547,570,663],"impact":[74],"selective":[76],"pressure":[77],"on":[78,143,176,828],"MM":[79],"clonal":[80],"architecture":[81],"mutational":[83,718],"load":[84,719],"has":[85],"not":[86,90,715],"been":[87,227],"assessed.":[88],"Although":[89],"damaging":[93],"agent":[94],"there":[95,488],"apparent":[98],"effect":[99],"len":[102,128,195,201,234,282,315,363,526,568,590,600,637,675,696,713,728],"increasing":[103],"the":[104,125,131,152,184,247,250,254,261,267,365,383,613,623,649,666,685,689,700,717],"risk":[105,121,322,507],"second":[107],"cancers":[108],"suggestion":[111],"that":[112,127,712],"it":[113],"could":[114],"select":[115,724],"aggressive":[117],"clones":[118],"in":[119,206,260,266,327,398,401,405,433,494,522,540,555,579,622,632,694],"high":[120,506],"disease.":[122],"We":[123,217,710],"addressed":[124],"hypothesis":[126],"may":[129,723],"increase":[130],"rate":[132],"mutation":[134,549,572,614,650,667],"at":[135,246,331,350,370,376,388,394,410,552,575,617,626,653,669,704,720,731],"relapse":[136,251,274,353,377,395,450,487,553,578,620,707,721],"performing":[138],"whole":[139],"exome":[140],"sequencing":[141],"(WES)":[142],"70":[144,177,255],"paired":[145],"presentation/relapse":[146,178,474,692],"samples":[147],"from":[148,180],"patients":[149,181,219,238,287,330,361,452,463,484,500,515,595,629],"enrolled":[150,182,259],"to":[151,170,183,229,273,519,592,608,641,647,674,737],"Myeloma":[153],"XI":[154],"trial":[155],"(MXI),":[156],"35":[157,164,286],"whom":[159],"received":[160,586,599],"not.":[165],"Methods":[166],"WES":[167],"was":[168,278,308,325,354,372,390,480,489,550,573,615,651,672],"performed":[169],"median":[172,271,306,343,366,384],"depth":[173],"125x":[175],"pairs":[179],"MXI":[185,187],"trial.":[186],"phase":[190],"III":[191],"study":[192,687],"comparing":[193,688],"thalidomide,":[194],"bortezomib":[197],"induction":[198,223,638],"combinations":[199],"vs":[202,283,374,392,706],"observation":[203,648],"treatment":[205],"both":[207,443,654],"transplant":[208,212],"eligible":[209],"(TE)":[210],"non-eligible":[213],"(TNE)":[214],"NDMM":[215],"patients.":[216,439],"selected":[218],"who":[220,558,582],"had":[221,239,442,559],"completed":[222],"+/-":[224],"ASCT":[225,640],"randomised":[228,607,646,673],"receive":[230],"therapy":[232],"or":[235,545,834],"observation.":[236,609],"All":[237],"disease":[240,323],"progression":[241],"determined":[242],"IMWG":[244],"criteria":[245],"time":[248,272,655],"sample.":[252],"Of":[253],"patients,":[256],"30":[257],"were":[258,431,517,538,606,634],"TE":[262],"pathway":[263],"40":[265],"TNE":[268],"pathway.":[269],"following":[275],"randomisation":[277],"323":[279],"days":[280,566,588],"(296":[281],"325":[284],"observation).":[285],"(50%)":[288],"achieved":[289,560,583,603],"CR":[291,562,584,604],"as":[292],"their":[293],"best":[294],"response,":[295],"26":[296],"(37%)":[297],"VGPR":[299],"9":[301],"(13%)":[302,499],"PR.":[304],"age":[307],"66":[309],"69":[311],"those":[313,317,380],"receiving":[314,362],"being":[318,381],"observed":[319,382],"respectively.":[320],"High":[321],"status":[324,496],"confirmed":[326],"33":[328],"(47%)":[329],"presentation":[332,351,371,389,411,576,618,670,705],"(\u2265":[333],"1of":[334],"t(4;14),":[335],"t(14;16),":[336],"t(14;20),":[337],"+1q,":[338],"-17p,":[339],"-1p).":[340],"Results":[341],"number":[344,367,385,476,701],"non-silent":[346],"mutations":[347,454,465,521,537,598,631,703,726],"(NSM)":[348],"found":[349,518,539,551],"37":[355,373,437],"41":[357],"respectively":[358],"(p=0.25).":[359],"In":[360,379,610,643],"NSM":[369,387],"34":[375],"(p=0.69).":[378],"42":[391],"52":[393],"(p=0.21).":[396],"Mutations":[397],"genes":[399,523],"important":[400],"myeloma":[402,693],"pathogenesis":[403],"seen":[404,432,574,616,652],"more":[406],"than":[407],"one":[408,611,644],"patient":[409,441,557,581,612],"included":[412],"KRAS":[413,447,457],"(16),":[414],"NRAS":[415,445,468],"(14),":[416],"DIS3":[417,459],"(6),":[418],"HIST1H1E":[419],"(2),":[420,422,424,467,469,533],"RB1":[421],"EGR1":[423],"TP53":[425,470],"(2)":[426],"FAM46C":[428],"(2).":[429,535],"These":[430],"total":[435],"(53%)":[438],"One":[440],"mutation.":[448],"At":[449,486],"7":[451],"lost":[453],"(NRAS":[455],"(3),":[456,458],"(1))":[460],"6":[462],"gained":[464],"(KRAS":[466],"(1),":[471,529,531],"FAM46C(1)).":[472],"Paired":[473],"copy":[475],"(CN)":[477],"data":[478],"(MLPA)":[479],"available":[481],"38":[483],"(54%).":[485],"evidence":[490],"change":[493],"CN":[495,502],"5":[498],"gaining":[501],"changes":[503],"(gain":[508],"1q":[509],"(4),":[510],"del":[511],"17p":[512],"(1).":[513],"Six":[514],"(9%)":[516],"have":[520],"action;":[527],"CRBN":[528,548],"IRF4":[530,571],"DDB1":[532,597],"SLC16A1":[534,633],"No":[536],"ROC1,":[543],"CUL4":[544],"BSG.":[546],"only,":[554],"undergone":[564],"232":[565],"maintenance.":[569],"754":[587],"prior":[591],"relapse.":[593,627],"Both":[594,628],"induction,":[601],"ASCT,":[602],"whilst":[621],"other":[624],"only":[625,671],"treated":[635,697],"CR.":[642],"patient,":[645],"points":[656],"they":[658],"relapsed":[659,678],"after":[660,679],"156":[661],"days.":[662,681],"other,":[664],"present":[668,732],"256":[680],"Conclusions":[682],"This":[683],"largest":[686],"genetics":[690],"population.":[698],"Overall,":[699],"remained":[708],"stable.":[709],"show":[711],"does":[714],"affect":[716],"but":[722],"conferring":[727],"resistance":[729],"although":[730],"further":[733],"analysis":[734],"required":[736],"confirm":[738],"this.":[739],"Disclosures":[740],"Jones:":[741],"Celgene:":[742,781,812,840,859,884],"Honoraria,":[743,748,757,771,776,783,790,797,803,814,819,861,871,881,886,896,901,906,911],"Research":[744,758,777,784,791,807,815,862,875,890,912,922],"Funding.":[745],"Pawlyn:Celgene:":[746],"Consultancy,":[747,756,763,767,770,775,782,789,796,802,810,813,818,838,841,844,847,852,855,860,865,870,880,885,895,900,905,910,915,919],"Other:":[749,798,804,820,848,856,872,887],"Travel":[750,799,805,821,849,857,873,888],"Support;":[751,850,858],"Takeda":[752],"Oncology:":[753],"Consultancy.":[754,868],"Cook:Amgen:":[755],"Funding,":[759,778,785,792,876,891],"Speakers":[760,772,779,786,793,877,882,892,897,902,907],"Bureau;":[761,773,780,787,878,883,893,898,903],"Glycomimetics:":[762],"Honoraria;":[764,768,811,839,842,853,866,916,920],"Bristol-Myers":[765],"Squibb:":[766],"Sanofi:":[769],"Takeda:":[774,817,843,854,914],"Janssen:":[788,801,864,904,921],"Bureau.":[794,908],"Jenner:Amgen:":[795],"support;":[800],"support,":[806,874,889],"Funding;":[808,816,863,913,923],"Novartis:":[809],"support.":[822],"Drayson:Abingdon":[823],"Health:":[824],"Equity":[825],"Ownership,":[826],"Membership":[827],"entity's":[830],"Board":[831],"Directors":[833],"advisory":[835],"committees.":[836],"Davies:Janssen:":[837],"Honoraria.":[845],"Kaiser:BMS:":[846],"Amgen:":[851,899],"Chugai:":[867],"Jackson:Takeda:":[869],"MSD:":[879],"Roche:":[894],"Morgan:Celgene:":[909],"Bristol":[917],"Meyers:":[918],"Univ":[924],"AR":[926],"Medical":[928],"Sciences:":[929],"Employment.":[930]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2017-02-17T00:00:00"}